145 related articles for article (PubMed ID: 36245145)
1. Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.
Rastogi A; Kulkarni SA; Deshpande SK; Driver V; Barman H; Bal A; Deshmukh M; Nair H
Adv Wound Care (New Rochelle); 2023 Aug; 12(8):429-439. PubMed ID: 36245145
[TBL] [Abstract][Full Text] [Related]
2. Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts.
Kulkarni SA; Deshpande SK; Rastogi A
Front Endocrinol (Lausanne); 2022; 13():926129. PubMed ID: 36082077
[TBL] [Abstract][Full Text] [Related]
3. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
Rastogi A; Kulkarni SA; Agarwal S; Akhtar M; Arsule S; Bhamre S; Bhosle D; Desai S; Deshmukh M; Giriraja KV; Jagannath J; Kashiva RY; Kesavan R; Khandelwal D; Kolte S; Kongara S; Darivemula AK; Madhusudan C; Pyare Saheb Qureshi MAH; Ramu M; Rathod G; Yalamanchi SR; Shakya S; Shetty P; Singh S; Deshpande SK; Viswanathan V; Unnikrishnan AG
JAMA Netw Open; 2023 May; 6(5):e2311509. PubMed ID: 37184839
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Low-Frequency, Noncontact Airborne Ultrasound Therapy (Glybetac) For Neuropathic Diabetic Foot Ulcers: A Randomized, Double-Blind, Sham-Control Study.
Rastogi A; Bhansali A; Ramachandran S
Int J Low Extrem Wounds; 2019 Mar; 18(1):81-88. PubMed ID: 30836809
[TBL] [Abstract][Full Text] [Related]
6. Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II.
Gugerell A; Gouya-Lechner G; Hofbauer H; Laggner M; Trautinger F; Almer G; Peterbauer-Scherb A; Seibold M; Hoetzenecker W; Dreschl C; Mildner M; Ankersmit HJ
Trials; 2021 Jan; 22(1):10. PubMed ID: 33407796
[TBL] [Abstract][Full Text] [Related]
7. Intensive Glycemic Control for Diabetic Foot Ulcer Healing: A Multicentric, Randomized, Parallel Arm, Single-Blind, Controlled Study Protocol (INGLOBE Study).
Rastogi A; Mukhopadhyay S; Sahoo JP; Mennon A; Ghosh A; Jha S; Bal A
Int J Low Extrem Wounds; 2022 Dec; 21(4):443-449. PubMed ID: 32907433
[TBL] [Abstract][Full Text] [Related]
8. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
Balingit PP; Armstrong DG; Reyzelman AM; Bolton L; Verco SJ; Rodgers KE; Nigh KA; diZerega GS
Wound Repair Regen; 2012; 20(4):482-90. PubMed ID: 22672145
[TBL] [Abstract][Full Text] [Related]
9. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
10. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
[TBL] [Abstract][Full Text] [Related]
11. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
[TBL] [Abstract][Full Text] [Related]
12. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
[TBL] [Abstract][Full Text] [Related]
13. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Foot Exercises on Wound Healing in Type 2 Diabetic Patients With a Foot Ulcer: A Randomized Control Study.
Eraydin Ş; Avşar G
J Wound Ostomy Continence Nurs; 2018; 45(2):123-130. PubMed ID: 29521922
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the Novel Formulation of Topical Liothyronine and Liothyronine-insulin in Mild to Moderate Diabetic Foot Ulcer: A Randomized, Triple-blind Clinical Trial.
Saghafi F; Khalilzadeh SH; Ramezani V; Pasandeh F; Fallahzadeh H; Sahebnasagh A
Curr Med Chem; 2024; 31(21):3232-3243. PubMed ID: 37226792
[TBL] [Abstract][Full Text] [Related]
16. ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trial.
Yang JY; Chen CC; Chang SC; Yeh JT; Huang HF; Lin HC; Lin SH; Lin YH; Wei LG; Liu TJ; Hung SY; Yang HM; Chang HH; Wang CH; Tzeng YS; Huang CH; Chou CY; Lin YS; Yang SY; Chen HM; Lin JT; Cheng YF; Young GH; Huang CF; Kuo YC; Dai NT
EClinicalMedicine; 2022 Sep; 51():101497. PubMed ID: 35844773
[TBL] [Abstract][Full Text] [Related]
17. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
[TBL] [Abstract][Full Text] [Related]
18. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial.
Razzaghi R; Pidar F; Momen-Heravi M; Bahmani F; Akbari H; Asemi Z
Biol Trace Elem Res; 2018 Feb; 181(2):207-215. PubMed ID: 28540570
[TBL] [Abstract][Full Text] [Related]
19. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Aloe vera/ Plantago Major Gel in Diabetic Foot Ulcer: A Randomized Double-Blind Clinical Trial.
Najafian Y; Khorasani ZM; Najafi MN; Hamedi SS; Mahjour M; Feyzabadi Z
Curr Drug Discov Technol; 2019; 16(2):223-231. PubMed ID: 29336265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
